Articles Tagged With: cognition
-
Drinking More Coffee May Protect Against Cognitive Decline
Among adults older than age 60 years, heavier coffee consumption was associated with slower cognitive decline in executive function and less beta-amyloid accumulation.
-
Tailoring Dietary Recommendations to Protect Cognitive Health
Preventing inflammation as patients age is becoming key focus of lowering dementia risk.
-
Oral Contraceptives Can Affect Verbal Working Memory, Cognition
New research shows that oral contraceptive use does not affect people’s behavior, feelings, and gender self-concept, although it does appear to affect cognition. Women who used oral contraceptives showed no differences in openness, conscientiousness, neuroticism, extroversion, and agreeableness. -
Statins, Cognitive Decline, and Dementia
An analysis of the ASPREE database showed that with almost five years of follow-up, statins are not associated with cognitive decline or dementia in a large group of elderly subjects in whom multiple tests of cognition were performed serially.
-
Functional Cognitive Disorder: An Important Condition for Neurologists to Recognize
Functional cognitive disorder (FCD) is a term that can be used to describe cognitive difficulties that are present where there is no biologic cause, but a lack of consensus in diagnostic criteria limits its use in clinical practice and research. Ball and colleagues proposed an operational definition for FCD as the cognitive phenotype of functional neurological disorder.
-
Statins, Cognitive Decline, and Dementia
An analysis of the ASPREE database showed that with almost five years of follow-up, statins are not associated with cognitive decline or dementia in a large group of elderly subjects in whom multiple tests of cognition were performed serially. -
Researchers Observe No Connections Between Statin Therapy, Cognitive Decline
But randomized trials are needed to better detail long-term risk-benefit ratio. -
Long-Term Effects of Cholinesterase Inhibitors on Cognitive Decline and Mortality
Cholinesterase inhibitors are one of the few drug classes approved by the Food and Drug Administration for the treatment of patients with Alzheimer’s disease. This study shows a long-term benefit in slowing the decline of cognition, as measured by the Mini-Mental State Exam, but it is unclear if there is any benefit in quality of life.
-
Ketogenic Diet Improves Cognition, Daily Function in Alzheimer’s Disease Patients
In a randomized, crossover trial, patients with Alzheimer’s disease on a ketogenic diet for 12 weeks demonstrated improved cognition, daily function, and quality of life.
-
Cognitive Deficits in Patients Recovering from COVID-19
Hospitalized COVID-19 patients with cognitive complaints demonstrate reduced attention and executive dysfunction on formal cognitive testing consistent with the same frequency and pattern of cognitive changes associated with critical illness.